Moussa OUEDRAOGO

Dr. Moussa OUEDRAOGO

Sciences pharmaceutiques et appliquées, Université Joseph Ki-Zerbo, Ouagadougou, Centre, Burkina Faso
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NIKIEMA W. ARSENENIKIEMA W. ARSENE
NIKIEMA W. ARSENE
MOMoussa OUEDRAOGO
Moussa OUEDRAOGO
WOWindbedma Prisca Ouédraogo
Windbedma Prisca Ouédraogo
SFSouleymane Fofana
Souleymane Fofana
BOBORIS HONORE AMADOU OUEDRAOGO
BORIS HONORE AMADOU OUEDRAOGO
RSRASMANE SEMDE
RASMANE SEMDE
A robust, well-functioning immune system is the cornerstone of good health. Various factors may influence the immune system’s effectiveness, potentially leading to immune system failure. This review aims to provide an overview of the structure and action of immunomodulators isolated from African medicinal plants. The research was conducted according to PRISMA guidelines. Full-text access research articles published in English up to December 2023, including plant characteristics, isolated phytochemicals, and immuno-modulatory activities, were screened. The chemical structures of the isolated compounds were generated using ChemDraw® (version 12.0.1076), and convergent and distinctive signaling pathways were highlighted. These phytochemicals with demonstrated immunostimulatory activity include alkaloids (berberine, piperine, magnoflorine), polysaccharides (pectin, glucan, acemannan, CALB-4, GMP90-1), glycosides (syringin, cordifolioside, tinocordiside, aucubin), phenolic compounds (ferulic acid, vanillic acid, eupalitin), flavonoids (curcumin, centaurein, kaempferin, luteolin, guajaverin, etc.), terpenoids (oleanolic acid, ursolic acid, betulinic acid, boswellic acids, corosolic acid, nimbidin, andrographolides). These discussed compounds exert their effects through various mechanisms, targeting the modulation of MAPKs, PI3K-Akt, and NF-kB. These mechanisms can support the traditional use of medicinal plants to treat immune-related diseases. The outcomes of this overview are to provoke structural action optimization, to orient research on particular natural chemicals for managing inflammatory, infectious diseases and cancers, or to boost vaccine immunogenicity.

16 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SFSouleymane FOFANA
Souleymane FOFANA
CDCedric Delporte
Cedric Delporte
RERafaèle Calvo Esposito
Rafaèle Calvo Esposito
MOMoussa OUEDRAOGO
Moussa OUEDRAOGO
PAPierre Van Antwerpen
Pierre Van Antwerpen
Véronique MathieuVéronique Mathieu
Véronique Mathieu
Although Erythrina senegalensis is a plant widely used in traditional medicine in sub-Saharan Africa, its biological properties have been poorly investigated to date. We first characterized by conventional reactions the composition of several stem bark extracts and evaluated in acellular and cellular assays their pro- or antioxidant properties supported by their high phenolic and flavonoid content, particularly with the methanolic extract. The pro- or antioxidant effects observed did not correlate with their IC50 concentrations against five cancer cell lines determined by MTT assay. Indeed, the CH2Cl2 extract and its ethyl acetate (EtOAc) subfraction appeared more potent although they harbored lower pro- or antioxidant effects. Nevertheless, at equipotent concentration, both extracts induced ER- and mitochondria-derived vacuoles observed by fluorescent microscopy that further led to non-apoptotic cell death. LC coupled to high resolution MS investigations have been performed to identify chemical compounds of the extracts. These investigations highlighted the presence of compounds formerly isolated from E. senegalensis including senegalensein that could be retrieved only in the EtOAc subfraction but also thirteen other compounds, such as 16:3-Glc-stigmasterol and hexadecanoic acid, whose anticancer properties have been previously reported. Nineteen other compounds remain to be identified. In conclusion, E. senegalensis appeared rich in compounds with antioxidant and anticancer properties, supporting its use in traditional practice and its status as a species of interest for further investigations in anticancer drug research.

22 December 2021 in Plants
Verified
Journal Article
Open access
PDF file
SFSouleymane FOFANA
Souleymane FOFANA
MOMoussa OUEDRAOGO
Moussa OUEDRAOGO
RERafaèle Calvo Esposito
Rafaèle Calvo Esposito
WOWindbedema Prisca Ouedraogo
Windbedema Prisca Ouedraogo
CDCedric Delporte
Cedric Delporte
PGPierre Innocent Guissou
Pierre Innocent Guissou
The objective of this study was to carry out a systematic review of the substances isolated from the African medicinal plant Erythrina senegalensis, focusing on compounds harboring activities against cancer models detailed in depth herein at both in vitro and in vivo preclinical levels. The review was conducted through Pubmed and Google Scholar. Nineteen out of the forty-two secondary metabolites isolated to date from E. senegalensis displayed interesting in vitro and/or in vivo antitumor activities. They belonged to alkaloid (Erysodine), triterpenes (Erythrodiol, maniladiol, oleanolic acid), prenylated isoflavonoids (senegalensin, erysenegalensein E, erysenegalensein M, alpinumisoflavone, derrone, warangalone), flavonoids (erythrisenegalone, senegalensein, lupinifolin, carpachromene) and pterocarpans (erybraedine A, erybraedine C, phaseollin). Among the isoflavonoids called “erysenegalensein”, only erysenealenseins E and M have been tested for their anticancerous properties and turned out to be cytotoxic. Although the stem bark is the most frequently used part of the plant, all pterocarpans were isolated from roots and all alkaloids from seeds. The mechanisms of action of its metabolites include apoptosis, pyroptosis, autophagy and mitophagy via the modulation of cytoplasmic proteins, miRNA and enzymes involved in critical pathways deregulated in cancer. Alpinumisoflavone and oleanolic acid were studied in a broad spectrum of cancer models both in vitro and in preclinical models in vivo with promising results. Other metabolites, including carpachromen, phaseollin, erybraedin A, erysenegalensein M and maniladiol need to be further investigated, as they display potent in vitro effects.

1 May 2023 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
PDF file
EDEdwige T Delma
Edwige T Delma
MOMoussa OUEDRAOGO
Moussa OUEDRAOGO
AOAimé S Ouédraogo
Aimé S Ouédraogo
NIKIEMA W. ARSENENIKIEMA W. ARSENE
NIKIEMA W. ARSENE
MGMoustapha Abdoulaye Gambo
Moustapha Abdoulaye Gambo
PGPierre I Guissou
Pierre I Guissou
Purpose: This study aimed to provide pharmacological evidence of Pseudocedrela kotschyi and Ximenia americana in preventing or healing peptic ulcers claimed by traditional healers in Burkina Faso. Methods: The trunk bark of Pseudocedrela kotschyi and the roots bark of Ximenia americana (Olacaceae) were macerated in mixed ethanol/water (80:20), respectively, to obtain dried extracts. Two models of hydrochloric acid (HCl, 0.3 M/ethanol, 60%) and hypothermic stress-induced peptic ulcer were used. The cytoprotective effect of individual or combined plant extracts was assessed at 1; 10; 30mg/kg. bw. Then, the healing effect of the extracts at 10mg/kg.bw was evaluated within 21 days of treatment on the hydrochloric acid-induced ulcer model. The extracts’ antioxidant activity and phenolic content were assessed to support the plant extracts’ efficiency. Results: The extracts of P. kotschyi and X. americana at 10 mg/kg.bw reduced ulceration index in hydrochloric acid- and hypothermic stress-ulcer models by more than 83% and 65%, respectively. The extract from X. americana at 10mg/kg.bw allowed complete ulcer healing but not the association of the two plant extracts. The plant extracts had IC50of inhibition of DPPH radical lower than 5μg/mL and total ferric reducing antioxidant power of more than 77 mg EQAA/100mg. The total polyphenolic content was 64.82 ± 0.99 and 53.75 ± 1.39 mg EGA/g of dried extract of P. kotschyi and X. americana, respectively. Conclusion: X. americana extract is better than the combined two plant extracts in gastric cytoprotection and ulcer healing. Further investigations are needed to highlight mechanism-based effects.

28 March 2023 in Santé Publique
Verified
Journal Article
Closed access
DDDaniel Dori
Daniel Dori
ITInoussa Tapsoba
Inoussa Tapsoba
CSCharles Bavouma Sombié
Charles Bavouma Sombié
HZHermine Zimé-Diawara
Hermine Zimé-Diawara
MOMoussa OUEDRAOGO
Moussa OUEDRAOGO
RORasmata Ouédraogo-Traoré
Rasmata Ouédraogo-Traoré
Introduction : Les équipements de protection individuelle (EPI) sont utilisés par le personnel de santé dans le cadre des soins pour se protéger et protéger les patients contre les expositions diverses telles que les agents infectieux. Toutefois, le port de ces équipements n’est pas toujours optimal, surtout dans un contexte épidémique de transmission de la COVID-19. But de l’étude : La présente étude vise, dans le contexte spécifique de la COVID-19, à contribuer à l’amélioration des pratiques de port des EPI des agents de santé. Méthodes : Il s’agit d’une étude transversale descriptive conduite en 2020 au centre hospitalier universitaire pédiatrique Charles-de-Gaulle du Burkina Faso. Tous les agents de santé des unités de soins et du laboratoire ont été inclus. Les données ont été recueillies au moyen d’une grille d’observation lors de la première situation indiquant le port d’un EPI. L’appréciation des indications de port des EPI s’est basée sur les recommandations de la Société française d’hygiène hospitalière et sur le Guide technique de prévention et contrôle des infections associées aux soins au Burkina Faso. Résultats : Sur 350 agents ciblés, 296 ont été observés. Le port de la blouse, du masque et des gants était observé respectivement dans 95,60 %, 96,58 % et 97,63 % des cas. Cependant, les EPI tels que les lunettes de protection (1,56 %), le tablier (11,54 %) et la tenue professionnelle composée d’une tunique et d’un pantalon (46,28 %) étaient faiblement utilisés lors des soins médicaux. Conclusion : Les pratiques des agents de santé vis-à-vis du port de certains EPI restent insuffisantes. Un programme de formation et de sensibilisation sur les EPI doit être envisagé afin de renforcer la sécurité des patients et du personnel.

1 January 2025 in Journal of Toxicology
Verified
Journal Article
Open access
JOJoël Ouédraogo
Joël Ouédraogo
SISylvain Ilboudo
Sylvain Ilboudo
GOGeoffroy Gueswindé Ouédraogo
Geoffroy Gueswindé Ouédraogo
VDVirginie Dakuyo
Virginie Dakuyo
SOSalfo Ouédraogo
Salfo Ouédraogo
SOSylvin Ouédraogo
Sylvin Ouédraogo
In response to the COVID‐19 pandemic and following the World Health Organization’s call for action, several traditional medicine recipes were used without any scientific prerequisites concerning their safety. The current study investigated several short‐term toxicity parameters of SAYE PLUS, an antimalarial phytomedicine used in COVID‐19 patients in Burkina Faso. Following the guidelines of the Organisation for Economic Co‐operation and Development (OECD), the safety profile of SAYE PLUS was investigated in a battery of tests in rats and mice. In an acute toxicity study, male and female rats received a single oral dose of 2000 mg/kg b.w. of the test substance. For the subacute toxicity test, male and female rats received daily oral doses of 250, 500, and 1000 mg/kg b.w. for 28 days. Acute and subacute toxicity tests were accompanied by food and water intake, body and organ relative weight, and blood chemistry of animals recording. In mutagenicity, sperm quality, and lipid peroxidation tests, mice were orally exposed to daily oral doses of 500, 1000, and 2000 mg/kg for seven days. Single dose of 2000 mg/kg b.w. of SAYE PLUS did not cause rats mortality. The LD 50 is more than 2000 mg/kg b.w. Daily administration of SAYE PLUS for 28 days did not induce any significant change in the water or food intake and the body or organ relative weights of animals. Furthermore, no significant change was observed in biochemical parameters. In the test conditions, the recipe did not induce an increase of micronucleus or changes in sperm motility and number. However, all tested doses of SAYE PLUS induced a significant increase in MDA levels in mice serum. These results show that SAYE PLUS did not induce negative impacts on studied parameters, but the possible lipidic peroxidation observed must be further investigated for its mechanism and effects.